14.07.2017 • NewsElaine BurridgeSeedsDow

Dow Sells Brazilian Seed Assets to China’s CITIC

(c) Alexander Chernyakov
(c) Alexander Chernyakov

More details have emerged on Dow Chemical’s agreement to sell the Brazilian corn seed assets of its AgroSciences division to China’s CITIC Agri Fund for $1.1 billion. The divestment is required by Brazil’s antitrust authority as a condition for clearing the US group’s proposed merger with compatriot DuPont.

The deal includes seed processing plants and seed research centers, a copy of Dow AgroSciences' Brazilian corn germplasm bank, the Morgan seed brand and a license for the use of the Dow Sementes brand for a certain (undisclosed) period of time. The assets being sold generated revenues of about £287 million in 2016.

CITIC Agri Fund was established in June 2016 by CITIC Agriculture, a division of state-backed CITIC Ltd, together with Chinese seed firm Yuan Longping High-Tech Agriculture and two other listed agricultural companies.

China is rapidly expanding its presence in the global seeds industry, as illustrated by ChemChina’s recent $43 billion takeover of Swiss Syngenta. The Chinese group said last month that it is eager to pick up some of Bayer’s seeds assets, which the German firm will be forced to sell in order to gain international regulatory approval for its proposed $66 billion acquisition of Monsanto.

Dow reaffirmed that its merger with DuPont is expected to complete next month, with the intended spin-offs scheduled within 18 months of closure.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.